Literature DB >> 7664037

The crystal structure of human endothelin.

R W Janes1, D H Peapus, B A Wallace.   

Abstract

The three-dimensional structure of the vasoactive polypeptide endothelin, the most potent vasoconstrictor yet identified, has been determined by X-ray crystallography to 2.18 A resolution. This intermediate-sized structure was solved by molecular replacement techniques using a fragment of an NMR-derived model for initial phasing of the data. However, comparisons of the final X-ray structure with the many diverse models derived from NMR data indicate some important differences, especially in the carboxy-terminal region of the molecule: the entire carboxy terminal tail (residues 16-21) is helical in the crystal structure, but not in any of the NMR structures. This may be a functionally significant difference as this region is crucial for receptor binding and vasoactivity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7664037     DOI: 10.1038/nsb0594-311

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  15 in total

1.  Modeling and docking the endothelin G-protein-coupled receptor.

Authors:  A J Orry; B A Wallace
Journal:  Biophys J       Date:  2000-12       Impact factor: 4.033

2.  Features of a spatially constrained cystine loop in the p10 FAST protein ectodomain define a new class of viral fusion peptides.

Authors:  Christopher Barry; Tim Key; Rami Haddad; Roy Duncan
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

3.  Prediction of location of active sites in biologically active peptides.

Authors:  T Kikuchi
Journal:  J Protein Chem       Date:  1996-08

4.  Activation mechanism of endothelin ETB receptor by endothelin-1.

Authors:  Wataru Shihoya; Tomohiro Nishizawa; Akiko Okuta; Kazutoshi Tani; Naoshi Dohmae; Yoshinori Fujiyoshi; Osamu Nureki; Tomoko Doi
Journal:  Nature       Date:  2016-09-05       Impact factor: 49.962

5.  Free-energy landscape of molecular interactions between endothelin 1 and human endothelin type B receptor: fly-casting mechanism.

Authors:  Junichi Higo; Kota Kasahara; Mitsuhito Wada; Bhaskar Dasgupta; Narutoshi Kamiya; Tomonori Hayami; Ikuo Fukuda; Yoshifumi Fukunishi; Haruki Nakamura
Journal:  Protein Eng Des Sel       Date:  2019-12-31       Impact factor: 1.650

6.  Development of agonists of endothelin-1 exhibiting selectivity towards ETA receptors.

Authors:  Chantal Langlois; Myriam Létourneau; Philipe Lampron; Véronique St-Hilaire; Alain Fournier
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

Review 7.  The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house?

Authors:  N S Kirkby; P W F Hadoke; A J Bagnall; D J Webb
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

8.  Toward the estimation of the absolute quality of individual protein structure models.

Authors:  Pascal Benkert; Marco Biasini; Torsten Schwede
Journal:  Bioinformatics       Date:  2010-12-05       Impact factor: 6.937

9.  Improving NMR protein structure quality by Rosetta refinement: a molecular replacement study.

Authors:  Theresa A Ramelot; Srivatsan Raman; Alexandre P Kuzin; Rong Xiao; Li-Chung Ma; Thomas B Acton; John F Hunt; Gaetano T Montelione; David Baker; Michael A Kennedy
Journal:  Proteins       Date:  2009-04

Review 10.  Endothelin.

Authors:  Anthony P Davenport; Kelly A Hyndman; Neeraj Dhaun; Christopher Southan; Donald E Kohan; Jennifer S Pollock; David M Pollock; David J Webb; Janet J Maguire
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.